Therapeutic conference intelligence

    70 therapeutic conferences across Europe and the US, with potential attendees, brands, industry sessions and company announcements for each, to help you prep for a conference or decide which ones are worth attending.

    Live example: ESMO Congress 2026Madrid, Spain23 to 27 October 2026
    32
    brands mapped
    33
    industry sessions
    3,000
    potential attendees

    Brand-to-congress mapping

    Athena BDA maps specific commercial and pipeline brands to each event, so you know exactly which brand teams have a reason to be there.

    Datroway
    AstraZenecaDaiichi Sankyo

    Indications

    Breast CancerLung Cancer

    Intent signals

    ADCIn-Clinic InfusionNew Indication Approval
    Elahere
    AbbVie

    Indications

    Ovarian Cancer

    Intent signals

    ADCCompanion DiagnosticComplex DosingIn-Clinic InfusionTesting Requirement
    Inlexzo
    J&JJanssen

    Indications

    Bladder Cancer

    Intent signals

    Complex DosingDeviceLaunch Brand
    Darovasertib
    ServierIdeaya

    Indications

    Uveal Melanoma

    Intent signals

    Pipeline Asset

    +28 more brands on the full ESMO conference page

    Potential attendee lists

    Each conference comes with a list of contacts working on the brands mapped to it, so you know who to go after before, during and after the event.

    3,000
    Potential attendees
    10
    Connections potentially attending
    Overlay your company’s LinkedIn connections to track warm leads who are attending
    Job title and companyMapped brands
    Global Commercial Associate Director, Breast Cancer (Launch)
    AstraZeneca
    EnhertuCamizestrantDatroway
    Executive Vice President Chief Commercial Officer
    Deciphera
    RomvimzaTirabrutinib
    Vice President Global Launch Lead TGCT
    Merck KGaA
    Pimicotinib

    Names and contact details available to Athena BDA clients

    Industry session detail

    Sponsored symposia, pipeline presentations and workshops, indexed by company, drug, time and room, so you can be in the right place when brand teams are.

    Industry satellite symposiumElahere
    AbbVie: Riding the wave of innovation towards personalised medicine in ovarian cancer
    23 Oct09:45 to 11:15Leon Auditorium, Hall 4
    Industry satellite symposiumOpdivo
    Bristol Myers Squibb: Optimizing the NSCLC treatment landscape: impact for today and insights for tomorrow
    23 Oct09:45 to 11:15Madrid Auditorium, Hall 4

    +31 more sessions on the full ESMO conference page

    Company announcements

    Press releases tied to the companies in attendance

    Regeneron6 Oct 2026

    investor.regeneron.com

    Regeneron will present 10 abstracts at ESMO 2026, featuring late-breaking Phase 3 overall survival data for Libtayo as an adjuvant treatment for high-risk cutaneous squamous cell carcinoma (CSCC). The company will also highlight final Phase 2 neoadjuvant CSCC data and showcase its expanding pipeline in cancer-associated thrombosis with updates on Factor XI inhibitors armebirart and onvecimabart.

    Pfizer28 Sep 2026

    www.pfizer.com

    Pfizer will present data from 45 abstracts at ESMO 2026, featuring 11 oral presentations across its breast, genitourinary, and lung cancer portfolios. Key highlights include late-breaking Phase 3 survival results for sigvotatug vedotin in lung cancer and Phase 2 efficacy data for the CDK4 inhibitor atirmociclib in metastatic breast cancer.

    More company announcements on the full ESMO conference page

    See how it works

    Book a 20-minute demo to run through the full brand mappings, attendee lists and sessions for the conferences on your calendar.